Masanori Terashima Selected Research

Splenectomy

3/2020	Disadvantages of Complete No. 10 Lymph Node Dissection in Gastric Cancer and the Possibility of Spleen-Preserving Dissection: Review.
12/2017	Amputation neuroma mimicking lymph node metastasis of remnant gastric cancer: a case report.
10/2013	Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
4/2010	[Histological complete response in a case of advanced gastric cancer treated by neo-adjuvant chemotherapy with S-1/CDDP].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Terashima Research Topics

Disease

141	Stomach Neoplasms (Stomach Cancer) 11/2022 - 11/2002
69	Neoplasms (Cancer) 09/2022 - 02/2002
24	Neoplasm Metastasis (Metastasis) 09/2022 - 04/2002
15	Lymphatic Metastasis 05/2022 - 09/2007
11	Adenocarcinoma 03/2021 - 10/2004
7	Postgastrectomy Syndromes 05/2022 - 06/2014
5	Anorexia 01/2022 - 06/2007
4	Leukopenia 01/2022 - 02/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 06/2010
4	Body Weight (Weight, Body) 01/2020 - 10/2003
3	Neutropenia 01/2022 - 03/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2004
3	Obesity 01/2022 - 01/2020
3	Pancreatic Fistula (Pancreatic Fistulas) 03/2020 - 11/2011
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 04/2002
3	Weight Loss (Weight Reduction) 01/2020 - 08/2009
3	Anastomotic Leak 03/2019 - 04/2012
3	Carcinoma (Carcinomatosis) 05/2017 - 01/2009
3	Hemorrhage 09/2012 - 03/2010
2	Microsatellite Instability 01/2021 - 10/2004
2	Residual Neoplasm 01/2021 - 05/2016
2	Emergence Delirium 12/2020 - 11/2018
2	Linitis Plastica 05/2020 - 01/2019
2	Infections 03/2020 - 04/2012
2	Ascites 01/2020 - 04/2010
2	Adenoma (Adenomas) 07/2019 - 06/2007
2	Malnutrition (Nutritional Deficiencies) 12/2018 - 04/2018
2	Wounds and Injuries (Trauma) 12/2017 - 09/2017
2	Surgical Wound Infection 12/2017 - 09/2017
2	Pneumonia (Pneumonitis) 07/2016 - 05/2016
2	Nausea 01/2016 - 06/2007
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 07/2015 - 12/2002
2	Breast Neoplasms (Breast Cancer) 12/2012 - 02/2005
2	Diarrhea 06/2007 - 02/2006
2	Hand-Foot Syndrome 02/2006 - 01/2003
2	Carcinogenesis 10/2004 - 09/2003
1	Febrile Neutropenia 01/2022
1	Constipation 11/2021
1	Nonpenetrating Wounds 11/2021
1	Gallstones (Gallstone) 11/2021
1	Cholelithiasis 11/2021
1	Hepatic Infarction 02/2021
1	Ischemia 02/2021

Drug/Important Bio-Agent (IBA)

10	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2003
9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2003
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2011
9	Proteins (Proteins, Gene)FDA Link 07/2019 - 10/2003
8	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 11/2002
6	Capecitabine (Xeloda)FDA Link 02/2019 - 01/2003
5	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2022 - 12/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 10/2004
5	Messenger RNA (mRNA)IBA 01/2012 - 02/2002
4	Indicators and Reagents (Reagents)IBA 03/2022 - 01/2012
4	S-1 plus cisplatinIBA 03/2021 - 04/2014
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2003
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2020 - 01/2017
4	Thymidylate SynthaseIBA 07/2015 - 12/2002
3	TegafurIBA 03/2017 - 01/2003
3	Imatinib Mesylate (Gleevec)FDA Link 06/2015 - 04/2002
2	CreatinineIBA 01/2022 - 01/2003
2	NucleotidesIBA 01/2022 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Leucovorin (Folinic Acid)FDA Link 11/2021 - 01/2020
2	titanium silicide (TS-1)IBA 08/2017 - 11/2012
2	Insulin (Novolin)FDA Link 03/2017 - 09/2009
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 12/2012
2	EnzymesIBA 07/2015 - 01/2003
2	Thymidine PhosphorylaseIBA 07/2015 - 01/2003
2	ProteomeIBA 10/2014 - 06/2011
2	Adenosine Triphosphate (ATP)IBA 08/2011 - 12/2002
2	Pharmaceutical PreparationsIBA 02/2006 - 01/2003
1	ORALIT (ORS)IBA 09/2022
1	Therapeutic UsesIBA 01/2022
1	AntibodiesIBA 01/2022
1	ParaffinIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	Amylases FDA Link 04/2021

Therapy/Procedure

104	Gastrectomy 05/2022 - 04/2002
37	Drug Therapy (Chemotherapy) 05/2022 - 12/2002
28	Therapeutics 03/2022 - 11/2002
25	Adjuvant Chemotherapy 11/2022 - 01/2003
22	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 04/2010
7	Neoadjuvant Therapy 03/2021 - 04/2010
6	Hepatectomy 04/2020 - 09/2012
5	Immunotherapy 05/2022 - 12/2002
4	Radiotherapy 05/2022 - 12/2002
4	Operative Surgical Procedures 02/2021 - 03/2010
4	Splenectomy 03/2020 - 04/2010
3	Minimally Invasive Surgical Procedures 11/2021 - 07/2015
3	Length of Stay 11/2018 - 07/2016
3	Sutures (Suture) 12/2017 - 03/2010
3	Combination Drug Therapy (Combination Chemotherapy) 09/2007 - 11/2002
2	Gastroenterostomy 12/2017 - 07/2015
2	Drug Tapering 01/2017 - 02/2006
2	Laparotomy 11/2015 - 04/2010
2	Intravenous Infusions 03/2003 - 11/2002
1	Combined Modality Therapy 05/2022
1	Esophagectomy 03/2022
1	Vagotomy 11/2021